Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”
Sign Up to like & getrecommendations! Published in 2020 at "PharmacoEconomics"
DOI: 10.1007/s40273-020-00973-9
Abstract: We appreciate the interest that Manning and readers have shown in orphan drug policy [1]. The incentives established in the 1983 Orphan Drug Act have undoubtedly become a success story helping to create new markets… read more here.
Keywords: market exclusivity; generic biosimilar; market; drug ... See more keywords
Market Exclusivity and the Right to Health in South Africa: A Primer for Tackling the Paradox
Sign Up to like & getrecommendations! Published in 2020 at "Journal of African Law"
DOI: 10.1017/s0021855320000029
Abstract: Abstract South Africa remains confronted with challenges to the realization of the right to healthcare services, shaped by both national and global dynamics. The proliferation of exclusivity regimes in intellectual property (IP) rule-making poses a… read more here.
Keywords: market exclusivity; health; exclusivity right; south ... See more keywords
Protect against market exclusivity in the fight against COVID-19.
Sign Up to like & getrecommendations! Published in 2020 at "Nature Medicine"
DOI: 10.1038/s41591-020-0876-6
Abstract: Patents and other intellectual properties could slow down the scale-up and accessibility of treatments and vaccines against COVID-19. read more here.
Keywords: exclusivity fight; market exclusivity; medicine; protect market ... See more keywords